Search

everythinglearnresearchcommunity

for

Search:↓

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Finasteride negatively affects fish reproduction and gonadal development.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

No treatment is clearly better for central serous chorioretinopathy, and more research is needed.

Cepharanthine can potentially treat gastric cancer by stopping tumor growth.

Hormones are crucial for regulating body functions and imbalances can lead to health issues.

A man fainted and felt unwell after using a strong hair growth product, but got better when he stopped using it.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Low androgen levels can still cause female pattern hair loss.

Cellulose nanocrystals are promising for making effective, sustainable sensors for various uses.

Pregnancy can cause skin changes and affect existing skin conditions, with limited treatment options due to the need for fetal safety.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Living with lupus as both a patient and doctor improved understanding and care for others.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

A fungus ball in the lung can cause coughing up blood in SLE patients.

Sex hormones do not cause oral lichen planus.

JSLE patients often have more hormone and metabolism issues, so regular check-ups and preventing obesity can help.

A man with Isaac's syndrome affecting only one side of his body improved after immune system-targeted treatment.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Eplerenone, a mineralocorticoid receptor antagonist, was found to promote hair growth in human hair follicles.